Influenza, pneumococcal and herpes zoster vaccination rates among patients over 65 years of age, related factors, and their knowledge and attitudes
Tóm tắt
In this study, we aimed to determine influenza, pneumococcal, and herpes zoster (HZ) vaccination status, among patients aged 65 or above, and to determine their level of knowledge about these vaccines and the factors affecting the vaccination rates. This was a cross-sectional descriptive study conducted through face-to-face interviews with patients who were admitted to Gemerek State Hospital Family Medicine Clinics. The questionnaire prepared by the researchers following the literature review was applied by researchers. The study included a total of 326 participants with a mean age of 71.59 ± 6.96 (min: 65, max: 96). Influenza, pneumococcal, and HZ vaccination rates were 21.8% (n = 71), 4.3% (n = 14), and 1.8% (n = 6), respectively. The odds ratio (OR) in the patients for whom influenza vaccination was recommended was calculated to be 15.25 compared to those for whom influenza vaccination was not recommended (95% CI 8.73–26.64, p < 0.001), OR in the patients for whom pneumococcal vaccination was recommended was calculated to be 257.5 compared to those for whom pneumococcal vaccination was not recommended (95% CI 50.75–1306.44, p < 0.001), and OR in the patients for whom HZ vaccination was recommended was calculated to be 126.0 compared to those for whom HZ vaccination was not recommended (95% CI 18.59–853.92, p < 0.001). The main findings of the present study are that the vaccination rate for all three vaccines is low, vaccination recommendation by a physician significantly increases vaccination rates, and the vaccination rate of patients, who have been informed by the physician about the vaccine, is higher.
Tài liệu tham khảo
World Health Organization (2019) Aging and health: fact sheet [Internet]. http://www.who.int/news-room/fact-sheets/detail/ageing-and-health. Accessed 24 Mar 2019
Turkish Statistical Institute (2017) Main statistics results of 2017: population and demography, population statistics [Internet]. http://www.turkstat.gov.tr/Start.do. Accessed 24 Mar 2019
Lang PO, Aspinall R (2014) Vaccination in the elderly: what can be recommended? Drugs Aging 31:581–599. https://doi.org/10.1007/s40266-014-0193-1
Iuliano AD, Roguski KM, Chang HH et al (2018) Estimates of global seasonal influenza associated respiratory mortality: a modelling study. Lancet 391:1285–1300. https://doi.org/10.1016/S0140-6736(17)33293-2
Montecino-Rodriguez E, Berent-Maoz B, Dorshkind K (2013) Causes, consequences, and reversal of immune system aging. J Clin Invest 123:958–965. https://doi.org/10.1172/JCI64096
World Health Organization (2012) Vaccines against influenza. WHO position paper, 2012. https://www.who.int/immunization/position_papers/PP_influenza_november2012_summary.pdf. Accessed 24 Mar 2019
Jain S, Self WH, Wunderink RG et al (2015) Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med 373:415–427. https://doi.org/10.1056/NEJMoa1500245
File TM Jr, Marrie TJ (2010) Burden of community-acquired pneumonia in North American adults. Postgrad Med 122:130–141. https://doi.org/10.3810/pgm.2010.03.2130
CDC (2018) Recommended immunizations for adults: by age [Internet]. https://www.cdc.gov/vaccines/schedules/downloads/adult/adult-schedule-easy-read.pdf. Accessed 24 Mar 2019
Centers for Disease Control and Prevention (2017) Shingles. Clinical overview—varicella vaccine, herpes zoster. http://www.cdc.gov/shingles/hcp/clinical-overview.html. Accessed 24 Mar 2019
Langan SM, Minassian C, Smeeth L et al (2014) Risk of stroke following herpes zoster: a self-controlled case-series study. Clin Infect Dis 58:1497–1503. https://doi.org/10.1093/cid/ciu098
Johnson RW, Bouhassira D, Kassianos G et al (2010) The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med 8:37–50. https://doi.org/10.1186/1741-7015-8-37
European Centre for Disease Prevention and Control (2017) Seasonal influenza vaccination in Europe—vaccination recommendations and coverage rates for eight influenza seasons (2007–2008 to 2014–2015). https://ecdc.europa.eu/en/publicationsdata/seasonal-influenza-vaccination-europe-vaccination-recommendations-and-coverage-2007-2015. Accessed 24 Mar 2019
Mutlu HH, Coşkun FO, Sargın M (2018) The incidence and awareness of vaccination among people aged 65 and over applied to a family medicine outpatient clinic. Ank Med J 1:1–13. https://doi.org/10.17098/amj.408968
Erer OF, Karadeniz G, Gazibaba D (2013) Immunization in the chronic obstructive pulmonary disease: can we have really done it? İzmir Göğüs Hastan Derg 27:31–40 (in Turkish)
Bülbül Y, Öztuna F, Gülsoy A et al (2010) Doğu Karadeniz Bölgesinde kronik obstrüktif akciğer hastalığı: hastalık özellikleri ve influenza-pnömokok aşılama sıklığı. Türkiye Klinikleri Tıp Bilim Derg 30:24–29 (in Turkish)
Biberoğlu K, Biberoğlu S, Özbakkaloğlu M et al (2010) Haydi Büyükler Aşıya [İnternet]. Türk İç Hastalıkları Uzmanlık Derneği, Ankara. http://www.tihud.org.tr/main/content?ref=2&child=179. Accessed 24 Mar 2019
Naito T, Yokokawa H, Watanabe A (2018) Impact of the national routine vaccination program on 23- valent pneumococcal polysaccharide vaccine vaccination rates in elderly persons in Japan. J Infect Chemother 24:496–498. https://doi.org/10.1016/j.jiac.2018.01.004
Williams WW et al (2014) Surveillance of vaccination coverage among adult populations United States, 2014. CDC, morbidity and mortality weekly report, surveillance summaries. https://www.cdc.gov/mmwr/volumes/65/ss/ss6501a1.htm Accessed 24 Mar 2019
Lu PJ, Euler GL, Harpaz R (2011) Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008. Am J Prev Med 40:1–6. https://doi.org/10.1016/j.amepre.2010.10.012
Liu XC, Simmonds KA, Russell ML et al (2014) Herpes zoster vaccine (HZV): utilization and coverage 2009–2013, Alberta, Canada. BMC Public Health 14:1098. https://doi.org/10.1186/1471-2458-14-1098
Erdoğdu Hİ, Çatak B (2018) Influenza, pneumococcal and herpes zoster vaccination rates amongst people aged 65 years and older and related factors. Turk J Geriatr 21:498–506. https://doi.org/10.31086/tjgeri.2018.54
Langan SM, Smeeth L, Margolis DJ et al (2013) Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study. PLoS Med 10:e1001420. https://doi.org/10.1371/journal.pmed.1001420
Wang J, Ford LJ, Wingate L et al (2013) Effect of pharmacist intervention on herpes zoster vaccination in community pharmacies. J Am Pharm Assoc 53:46–53. https://doi.org/10.1331/JAPhA.2013.12019
Zimmerman RK, Nowalk MP, Bardella IJ et al (2004) Physician and practice factors related to influenza vaccination among the elderly. Am J Prev Med 26:1–10
Chang Y-C, Tung H-J, Hsu S-W et al (2016) Use of seasonal influenza vaccination and its associated factors among elderly people with disabilities in Taiwan: a population-based study. PLoS One 23:e0158075. https://doi.org/10.1371/journal.pone.0158075
CDC (2018) Shingles (Herpes Zoster) vaccination information for healthcare providers. https://www.cdc.gov/vaccines/vpd/shingles/hcp/index.html. Accessed 24 Mar 2019
Ünal S, Durusu Tanriöver M, Taş E (2015) The effects of educating family physicians and setting targets for vaccination on pneumococcal vaccination coverage rates. FLORA 20:10–15 (in Turkish)
Akman M, Sarısoy M, Uzuner A (2014) Altmış beş yaş üstü erişkinlerde aşılanma durumu ve bilgi düzeyleri. J Turk Fam Physician 5:19–23 (in Turkish)
Çiftci F, Şen E, Demir N et al (2017) Which factors effects patients belief and attitudes about influenza vaccination? Tuberk Toraks 65:308–316. https://doi.org/10.5578/tt.66324